Tripharma brings new solutions to pharma logistics in UAE
In 2014, Dubai-based Globalpharma joined Sanofi in a partnership to produce some of its generic medicines in the UAE. In the same year, Abu Dhabi’s Neopharma entered a deal with Pfizer’s Wyeth to make medicines for pain management, cardiovascular diseases and women’s health. Julphar opened its 12th factory in the UAE at Jebel Ali in November 2013.
These deals were evidence of the growth of pharma manufacturing in the country. In early 2019, there were 17 pharma manufacturing plants in the UAE, with 34 expected in the next five years. Meanwhile, in 2019, the total healthcare expenditure in the UAE is expected to reach AED 70.67 billion, an annual growth rate of 7.9 per cent, from AED 53.8bn last year.
It was into this robust market that Tripharma was launched last year, with a mission to bring exceptional pharma logistics to market in the UAE.
See our interview with Tripharma at Arab Health 2019
“Tripharma Logistics is a UAE-based 3PL operator, uniquely specialized in delivering bespoke solutions to clients in the global pharmaceutical and healthcare sectors,” says Richard Bell, managing director of RHS Logistics. “The company has been created as a joint venture between three leading international logistics providers – RHS Logistics (established in 1998 in Dubai, UAE), and two Italian partners Columbus Logistics (founded in 1988) and Montalti Worldwide Moving( MWM - founded in 1967) – both highly experienced in the pharmaceutical sector.”
According to Bell, this elite partnership combines each company’s long-standing expertise with a reputation for reliability and excellence, positioning Tripharma as the premier provider of pharmaceutical storage and distribution services in the GCC.
“One of the key feature that make us unique is the M2M (Manufacturer to Market) service capability,” he says. “TPL systems are capable of electronically integrating with manufacturer and distributor host systems to give seamless data transparency, controlled, and secured for each unit movement within the supply chain nodes.”
In addition to this, Tripharma is also particularly geared toward offering different kinds of pharma companies a flexible logistics solution. “Tripharma Logistics offers a multimodal 3PL platform, specifically tailored to the diverse needs of individual pharma organisations across the world,” explains Bell.
The focus then is on providing a personalised experience, underpinned by superior quality and transparency, with all of its experts trained in Europe. “Tripharma is uniquely placed to help clients, whatever their size and requirements, whether they’re looking to expand into the GCC region for the first time or optimize their supply chain with a logistics operator whose core capabilities are enhanced by an in-depth understanding of the pharmaceutical sector,” he adds.
The 3PL is also well-equipped to help pharma manufacturers in the fight against counterfeit medicines, which requires serialisation and track-and-trace capability. “The transformation of pharma business processes due to digitalisation will positively help in the battle against fake or counterfeit medicines,” says Bell. “Each pharma package that comes off the production line, with a unique identifier, usually a scan able barcode, is entered into an online database.”
Tripharma’s track-and-trace technologies such as handheld scanners, with validated software application capability, ensures drug containers can be monitored and checked against the database at each point in the value chain, from manufacturer to repackaging to customs clearance and transport.
“Our systems are capable of electronically integrating with manufacturer and distributor host systems to give a seamless data transparency, controlled, and secured for each unit movement within the supply chain nodes,” explains Bell.
Tripharma is also looking to future solutions for pharma security, such as Blockchain. Experts agree this will become the fundamental methodology to secure the pharma supply chain in the future. “We are ready to accept the method of working on a common platform to provide interoperable capability that never existed before,” says Bell. “Blockchain technology will augment our existing systems capability. Supply chain issues can be pinpointed in real time and addressed. In case of an illicit product transaction, recalls will be fast and accurate.”